# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
https://www.wsj.com/articles/bausch-plan-to-spin-off-eye-care-business-stuck-in-creditor-standoff-00e49ff8
RBC Capital analyst Douglas Miehm reiterates Bausch & Lomb (NYSE:BLCO) with a Outperform and maintains $20 price target.
HC Wainwright & Co. analyst Yi Chen maintains Bausch & Lomb (NYSE:BLCO) with a Buy and lowers the price target from ...
Deutsche Bank analyst Pito Chickering maintains Bausch & Lomb (NYSE:BLCO) with a Hold and raises the price target from $...
RBC Capital analyst Douglas Miehm reiterates Bausch & Lomb (NYSE:BLCO) with a Outperform and maintains $20 price target.
Needham analyst David Saxon reiterates Bausch & Lomb (NYSE:BLCO) with a Hold.
Tech stocks soared to their best session in five months on Wednesday, ahead of the highly anticipated Federal Open Market Commi...
Tech optimism is likely to abound on Wall Street as AI-levered stocks are feeding off the strength generated by Advanced Micro ...
2024 Financial Outlook2 Bausch + Lomb raised revenue and Adjusted EBITDA (non-GAAP)1 guidance for the full year of 2024 as fol...